Global Recombinant FSH Injections Supply, Demand and Key Producers, 2024-2030
The global Recombinant FSH Injections market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
The fertility preservation and infertility treatment market has witnessed significant growth in recent years, driven by factors such as increasing infertility rates, delayed pregnancies, advancements in assisted reproductive technologies (ART), and growing awareness. Fertility preservation technologies, including egg freezing and sperm banking, have gained popularity among individuals seeking to preserve their reproductive potential. In the infertility treatment segment, in vitro fertilization (IVF), intrauterine insemination (IUI), and other ART procedures have become mainstream options. Future developments are anticipated in areas such as personalized medicine, gene editing technologies, and improved success rates in ART procedures. The market is likely to see ongoing advancements, innovations, and collaborations aimed at addressing infertility challenges and expanding the range of options available to individuals and couples.
Follicle Stimulating Hormone (FSH) injections are pharmaceutical preparations containing the hormone FSH, a crucial component in the regulation of reproductive processes. FSH is produced by the pituitary gland and plays a key role in the stimulation of ovarian follicles in females and sperm production in males. FSH injections are commonly used in assisted reproductive technologies, such as in vitro fertilization (IVF), to enhance the development and maturation of multiple follicles in the ovaries. In fertility treatments, these injections help regulate and stimulate the ovaries to produce more eggs, increasing the chances of successful fertilization and pregnancy.
Human follicle stimulating hormone (FSH) includes urinary human follicle stimulating hormone (uFSH) and recombinant FSH (rFSH). According to expert consensus, recombinant follicle-stimulating hormone is available in two dosage forms: powder injection and water injection.
This report studies the global Recombinant FSH Injections production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Recombinant FSH Injections, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant FSH Injections that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Recombinant FSH Injections total production and demand, 2019-2030, (K Units)
Global Recombinant FSH Injections total production value, 2019-2030, (USD Million)
Global Recombinant FSH Injections production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Recombinant FSH Injections consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Recombinant FSH Injections domestic production, consumption, key domestic manufacturers and share
Global Recombinant FSH Injections production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Recombinant FSH Injections production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Recombinant FSH Injections production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Recombinant FSH Injections market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gonal-F (Merck), Follistim (Organon), Bravelle (Ferring), Menopur (Ferring), Fostimon (IBSA), Puregon (Organon), BEMFOLA (Gedeon Richter), Follitrope (LG Chem) and GenSci, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant FSH Injections market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Recombinant FSH Injections Market, By Region:
1. How big is the global Recombinant FSH Injections market?
2. What is the demand of the global Recombinant FSH Injections market?
3. What is the year over year growth of the global Recombinant FSH Injections market?
4. What is the production and production value of the global Recombinant FSH Injections market?
5. Who are the key producers in the global Recombinant FSH Injections market?
The fertility preservation and infertility treatment market has witnessed significant growth in recent years, driven by factors such as increasing infertility rates, delayed pregnancies, advancements in assisted reproductive technologies (ART), and growing awareness. Fertility preservation technologies, including egg freezing and sperm banking, have gained popularity among individuals seeking to preserve their reproductive potential. In the infertility treatment segment, in vitro fertilization (IVF), intrauterine insemination (IUI), and other ART procedures have become mainstream options. Future developments are anticipated in areas such as personalized medicine, gene editing technologies, and improved success rates in ART procedures. The market is likely to see ongoing advancements, innovations, and collaborations aimed at addressing infertility challenges and expanding the range of options available to individuals and couples.
Follicle Stimulating Hormone (FSH) injections are pharmaceutical preparations containing the hormone FSH, a crucial component in the regulation of reproductive processes. FSH is produced by the pituitary gland and plays a key role in the stimulation of ovarian follicles in females and sperm production in males. FSH injections are commonly used in assisted reproductive technologies, such as in vitro fertilization (IVF), to enhance the development and maturation of multiple follicles in the ovaries. In fertility treatments, these injections help regulate and stimulate the ovaries to produce more eggs, increasing the chances of successful fertilization and pregnancy.
Human follicle stimulating hormone (FSH) includes urinary human follicle stimulating hormone (uFSH) and recombinant FSH (rFSH). According to expert consensus, recombinant follicle-stimulating hormone is available in two dosage forms: powder injection and water injection.
This report studies the global Recombinant FSH Injections production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Recombinant FSH Injections, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant FSH Injections that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Recombinant FSH Injections total production and demand, 2019-2030, (K Units)
Global Recombinant FSH Injections total production value, 2019-2030, (USD Million)
Global Recombinant FSH Injections production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Recombinant FSH Injections consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Recombinant FSH Injections domestic production, consumption, key domestic manufacturers and share
Global Recombinant FSH Injections production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Recombinant FSH Injections production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Recombinant FSH Injections production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Recombinant FSH Injections market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gonal-F (Merck), Follistim (Organon), Bravelle (Ferring), Menopur (Ferring), Fostimon (IBSA), Puregon (Organon), BEMFOLA (Gedeon Richter), Follitrope (LG Chem) and GenSci, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant FSH Injections market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Recombinant FSH Injections Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Powder
- Liquid
- IVF and Embryo Transfer
- Infertility Treatment
- Gonal-F (Merck)
- Follistim (Organon)
- Bravelle (Ferring)
- Menopur (Ferring)
- Fostimon (IBSA)
- Puregon (Organon)
- BEMFOLA (Gedeon Richter)
- Follitrope (LG Chem)
- GenSci
1. How big is the global Recombinant FSH Injections market?
2. What is the demand of the global Recombinant FSH Injections market?
3. What is the year over year growth of the global Recombinant FSH Injections market?
4. What is the production and production value of the global Recombinant FSH Injections market?
5. Who are the key producers in the global Recombinant FSH Injections market?
1 SUPPLY SUMMARY
1.1 Recombinant FSH Injections Introduction
1.2 World Recombinant FSH Injections Supply & Forecast
1.2.1 World Recombinant FSH Injections Production Value (2019 & 2023 & 2030)
1.2.2 World Recombinant FSH Injections Production (2019-2030)
1.2.3 World Recombinant FSH Injections Pricing Trends (2019-2030)
1.3 World Recombinant FSH Injections Production by Region (Based on Production Site)
1.3.1 World Recombinant FSH Injections Production Value by Region (2019-2030)
1.3.2 World Recombinant FSH Injections Production by Region (2019-2030)
1.3.3 World Recombinant FSH Injections Average Price by Region (2019-2030)
1.3.4 North America Recombinant FSH Injections Production (2019-2030)
1.3.5 Europe Recombinant FSH Injections Production (2019-2030)
1.3.6 China Recombinant FSH Injections Production (2019-2030)
1.3.7 Japan Recombinant FSH Injections Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Recombinant FSH Injections Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Recombinant FSH Injections Major Market Trends
2 DEMAND SUMMARY
2.1 World Recombinant FSH Injections Demand (2019-2030)
2.2 World Recombinant FSH Injections Consumption by Region
2.2.1 World Recombinant FSH Injections Consumption by Region (2019-2024)
2.2.2 World Recombinant FSH Injections Consumption Forecast by Region (2025-2030)
2.3 United States Recombinant FSH Injections Consumption (2019-2030)
2.4 China Recombinant FSH Injections Consumption (2019-2030)
2.5 Europe Recombinant FSH Injections Consumption (2019-2030)
2.6 Japan Recombinant FSH Injections Consumption (2019-2030)
2.7 South Korea Recombinant FSH Injections Consumption (2019-2030)
2.8 ASEAN Recombinant FSH Injections Consumption (2019-2030)
2.9 India Recombinant FSH Injections Consumption (2019-2030)
3 WORLD RECOMBINANT FSH INJECTIONS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Recombinant FSH Injections Production Value by Manufacturer (2019-2024)
3.2 World Recombinant FSH Injections Production by Manufacturer (2019-2024)
3.3 World Recombinant FSH Injections Average Price by Manufacturer (2019-2024)
3.4 Recombinant FSH Injections Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Recombinant FSH Injections Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Recombinant FSH Injections in 2023
3.5.3 Global Concentration Ratios (CR8) for Recombinant FSH Injections in 2023
3.6 Recombinant FSH Injections Market: Overall Company Footprint Analysis
3.6.1 Recombinant FSH Injections Market: Region Footprint
3.6.2 Recombinant FSH Injections Market: Company Product Type Footprint
3.6.3 Recombinant FSH Injections Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Recombinant FSH Injections Production Value Comparison
4.1.1 United States VS China: Recombinant FSH Injections Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Recombinant FSH Injections Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Recombinant FSH Injections Production Comparison
4.2.1 United States VS China: Recombinant FSH Injections Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Recombinant FSH Injections Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Recombinant FSH Injections Consumption Comparison
4.3.1 United States VS China: Recombinant FSH Injections Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Recombinant FSH Injections Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Recombinant FSH Injections Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Recombinant FSH Injections Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Recombinant FSH Injections Production Value (2019-2024)
4.4.3 United States Based Manufacturers Recombinant FSH Injections Production (2019-2024)
4.5 China Based Recombinant FSH Injections Manufacturers and Market Share
4.5.1 China Based Recombinant FSH Injections Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Recombinant FSH Injections Production Value (2019-2024)
4.5.3 China Based Manufacturers Recombinant FSH Injections Production (2019-2024)
4.6 Rest of World Based Recombinant FSH Injections Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Recombinant FSH Injections Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Recombinant FSH Injections Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Recombinant FSH Injections Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Recombinant FSH Injections Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Powder
5.2.2 Liquid
5.3 Market Segment by Type
5.3.1 World Recombinant FSH Injections Production by Type (2019-2030)
5.3.2 World Recombinant FSH Injections Production Value by Type (2019-2030)
5.3.3 World Recombinant FSH Injections Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Recombinant FSH Injections Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 IVF and Embryo Transfer
6.2.2 Infertility Treatment
6.3 Market Segment by Application
6.3.1 World Recombinant FSH Injections Production by Application (2019-2030)
6.3.2 World Recombinant FSH Injections Production Value by Application (2019-2030)
6.3.3 World Recombinant FSH Injections Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Gonal-F (Merck)
7.1.1 Gonal-F (Merck) Details
7.1.2 Gonal-F (Merck) Major Business
7.1.3 Gonal-F (Merck) Recombinant FSH Injections Product and Services
7.1.4 Gonal-F (Merck) Recombinant FSH Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Gonal-F (Merck) Recent Developments/Updates
7.1.6 Gonal-F (Merck) Competitive Strengths & Weaknesses
7.2 Follistim (Organon)
7.2.1 Follistim (Organon) Details
7.2.2 Follistim (Organon) Major Business
7.2.3 Follistim (Organon) Recombinant FSH Injections Product and Services
7.2.4 Follistim (Organon) Recombinant FSH Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Follistim (Organon) Recent Developments/Updates
7.2.6 Follistim (Organon) Competitive Strengths & Weaknesses
7.3 Bravelle (Ferring)
7.3.1 Bravelle (Ferring) Details
7.3.2 Bravelle (Ferring) Major Business
7.3.3 Bravelle (Ferring) Recombinant FSH Injections Product and Services
7.3.4 Bravelle (Ferring) Recombinant FSH Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Bravelle (Ferring) Recent Developments/Updates
7.3.6 Bravelle (Ferring) Competitive Strengths & Weaknesses
7.4 Menopur (Ferring)
7.4.1 Menopur (Ferring) Details
7.4.2 Menopur (Ferring) Major Business
7.4.3 Menopur (Ferring) Recombinant FSH Injections Product and Services
7.4.4 Menopur (Ferring) Recombinant FSH Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Menopur (Ferring) Recent Developments/Updates
7.4.6 Menopur (Ferring) Competitive Strengths & Weaknesses
7.5 Fostimon (IBSA)
7.5.1 Fostimon (IBSA) Details
7.5.2 Fostimon (IBSA) Major Business
7.5.3 Fostimon (IBSA) Recombinant FSH Injections Product and Services
7.5.4 Fostimon (IBSA) Recombinant FSH Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Fostimon (IBSA) Recent Developments/Updates
7.5.6 Fostimon (IBSA) Competitive Strengths & Weaknesses
7.6 Puregon (Organon)
7.6.1 Puregon (Organon) Details
7.6.2 Puregon (Organon) Major Business
7.6.3 Puregon (Organon) Recombinant FSH Injections Product and Services
7.6.4 Puregon (Organon) Recombinant FSH Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Puregon (Organon) Recent Developments/Updates
7.6.6 Puregon (Organon) Competitive Strengths & Weaknesses
7.7 BEMFOLA (Gedeon Richter)
7.7.1 BEMFOLA (Gedeon Richter) Details
7.7.2 BEMFOLA (Gedeon Richter) Major Business
7.7.3 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Product and Services
7.7.4 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 BEMFOLA (Gedeon Richter) Recent Developments/Updates
7.7.6 BEMFOLA (Gedeon Richter) Competitive Strengths & Weaknesses
7.8 Follitrope (LG Chem)
7.8.1 Follitrope (LG Chem) Details
7.8.2 Follitrope (LG Chem) Major Business
7.8.3 Follitrope (LG Chem) Recombinant FSH Injections Product and Services
7.8.4 Follitrope (LG Chem) Recombinant FSH Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Follitrope (LG Chem) Recent Developments/Updates
7.8.6 Follitrope (LG Chem) Competitive Strengths & Weaknesses
7.9 GenSci
7.9.1 GenSci Details
7.9.2 GenSci Major Business
7.9.3 GenSci Recombinant FSH Injections Product and Services
7.9.4 GenSci Recombinant FSH Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 GenSci Recent Developments/Updates
7.9.6 GenSci Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Recombinant FSH Injections Industry Chain
8.2 Recombinant FSH Injections Upstream Analysis
8.2.1 Recombinant FSH Injections Core Raw Materials
8.2.2 Main Manufacturers of Recombinant FSH Injections Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Recombinant FSH Injections Production Mode
8.6 Recombinant FSH Injections Procurement Model
8.7 Recombinant FSH Injections Industry Sales Model and Sales Channels
8.7.1 Recombinant FSH Injections Sales Model
8.7.2 Recombinant FSH Injections Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Recombinant FSH Injections Introduction
1.2 World Recombinant FSH Injections Supply & Forecast
1.2.1 World Recombinant FSH Injections Production Value (2019 & 2023 & 2030)
1.2.2 World Recombinant FSH Injections Production (2019-2030)
1.2.3 World Recombinant FSH Injections Pricing Trends (2019-2030)
1.3 World Recombinant FSH Injections Production by Region (Based on Production Site)
1.3.1 World Recombinant FSH Injections Production Value by Region (2019-2030)
1.3.2 World Recombinant FSH Injections Production by Region (2019-2030)
1.3.3 World Recombinant FSH Injections Average Price by Region (2019-2030)
1.3.4 North America Recombinant FSH Injections Production (2019-2030)
1.3.5 Europe Recombinant FSH Injections Production (2019-2030)
1.3.6 China Recombinant FSH Injections Production (2019-2030)
1.3.7 Japan Recombinant FSH Injections Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Recombinant FSH Injections Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Recombinant FSH Injections Major Market Trends
2 DEMAND SUMMARY
2.1 World Recombinant FSH Injections Demand (2019-2030)
2.2 World Recombinant FSH Injections Consumption by Region
2.2.1 World Recombinant FSH Injections Consumption by Region (2019-2024)
2.2.2 World Recombinant FSH Injections Consumption Forecast by Region (2025-2030)
2.3 United States Recombinant FSH Injections Consumption (2019-2030)
2.4 China Recombinant FSH Injections Consumption (2019-2030)
2.5 Europe Recombinant FSH Injections Consumption (2019-2030)
2.6 Japan Recombinant FSH Injections Consumption (2019-2030)
2.7 South Korea Recombinant FSH Injections Consumption (2019-2030)
2.8 ASEAN Recombinant FSH Injections Consumption (2019-2030)
2.9 India Recombinant FSH Injections Consumption (2019-2030)
3 WORLD RECOMBINANT FSH INJECTIONS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Recombinant FSH Injections Production Value by Manufacturer (2019-2024)
3.2 World Recombinant FSH Injections Production by Manufacturer (2019-2024)
3.3 World Recombinant FSH Injections Average Price by Manufacturer (2019-2024)
3.4 Recombinant FSH Injections Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Recombinant FSH Injections Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Recombinant FSH Injections in 2023
3.5.3 Global Concentration Ratios (CR8) for Recombinant FSH Injections in 2023
3.6 Recombinant FSH Injections Market: Overall Company Footprint Analysis
3.6.1 Recombinant FSH Injections Market: Region Footprint
3.6.2 Recombinant FSH Injections Market: Company Product Type Footprint
3.6.3 Recombinant FSH Injections Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Recombinant FSH Injections Production Value Comparison
4.1.1 United States VS China: Recombinant FSH Injections Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Recombinant FSH Injections Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Recombinant FSH Injections Production Comparison
4.2.1 United States VS China: Recombinant FSH Injections Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Recombinant FSH Injections Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Recombinant FSH Injections Consumption Comparison
4.3.1 United States VS China: Recombinant FSH Injections Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Recombinant FSH Injections Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Recombinant FSH Injections Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Recombinant FSH Injections Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Recombinant FSH Injections Production Value (2019-2024)
4.4.3 United States Based Manufacturers Recombinant FSH Injections Production (2019-2024)
4.5 China Based Recombinant FSH Injections Manufacturers and Market Share
4.5.1 China Based Recombinant FSH Injections Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Recombinant FSH Injections Production Value (2019-2024)
4.5.3 China Based Manufacturers Recombinant FSH Injections Production (2019-2024)
4.6 Rest of World Based Recombinant FSH Injections Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Recombinant FSH Injections Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Recombinant FSH Injections Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Recombinant FSH Injections Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Recombinant FSH Injections Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Powder
5.2.2 Liquid
5.3 Market Segment by Type
5.3.1 World Recombinant FSH Injections Production by Type (2019-2030)
5.3.2 World Recombinant FSH Injections Production Value by Type (2019-2030)
5.3.3 World Recombinant FSH Injections Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Recombinant FSH Injections Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 IVF and Embryo Transfer
6.2.2 Infertility Treatment
6.3 Market Segment by Application
6.3.1 World Recombinant FSH Injections Production by Application (2019-2030)
6.3.2 World Recombinant FSH Injections Production Value by Application (2019-2030)
6.3.3 World Recombinant FSH Injections Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Gonal-F (Merck)
7.1.1 Gonal-F (Merck) Details
7.1.2 Gonal-F (Merck) Major Business
7.1.3 Gonal-F (Merck) Recombinant FSH Injections Product and Services
7.1.4 Gonal-F (Merck) Recombinant FSH Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Gonal-F (Merck) Recent Developments/Updates
7.1.6 Gonal-F (Merck) Competitive Strengths & Weaknesses
7.2 Follistim (Organon)
7.2.1 Follistim (Organon) Details
7.2.2 Follistim (Organon) Major Business
7.2.3 Follistim (Organon) Recombinant FSH Injections Product and Services
7.2.4 Follistim (Organon) Recombinant FSH Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Follistim (Organon) Recent Developments/Updates
7.2.6 Follistim (Organon) Competitive Strengths & Weaknesses
7.3 Bravelle (Ferring)
7.3.1 Bravelle (Ferring) Details
7.3.2 Bravelle (Ferring) Major Business
7.3.3 Bravelle (Ferring) Recombinant FSH Injections Product and Services
7.3.4 Bravelle (Ferring) Recombinant FSH Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Bravelle (Ferring) Recent Developments/Updates
7.3.6 Bravelle (Ferring) Competitive Strengths & Weaknesses
7.4 Menopur (Ferring)
7.4.1 Menopur (Ferring) Details
7.4.2 Menopur (Ferring) Major Business
7.4.3 Menopur (Ferring) Recombinant FSH Injections Product and Services
7.4.4 Menopur (Ferring) Recombinant FSH Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Menopur (Ferring) Recent Developments/Updates
7.4.6 Menopur (Ferring) Competitive Strengths & Weaknesses
7.5 Fostimon (IBSA)
7.5.1 Fostimon (IBSA) Details
7.5.2 Fostimon (IBSA) Major Business
7.5.3 Fostimon (IBSA) Recombinant FSH Injections Product and Services
7.5.4 Fostimon (IBSA) Recombinant FSH Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Fostimon (IBSA) Recent Developments/Updates
7.5.6 Fostimon (IBSA) Competitive Strengths & Weaknesses
7.6 Puregon (Organon)
7.6.1 Puregon (Organon) Details
7.6.2 Puregon (Organon) Major Business
7.6.3 Puregon (Organon) Recombinant FSH Injections Product and Services
7.6.4 Puregon (Organon) Recombinant FSH Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Puregon (Organon) Recent Developments/Updates
7.6.6 Puregon (Organon) Competitive Strengths & Weaknesses
7.7 BEMFOLA (Gedeon Richter)
7.7.1 BEMFOLA (Gedeon Richter) Details
7.7.2 BEMFOLA (Gedeon Richter) Major Business
7.7.3 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Product and Services
7.7.4 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 BEMFOLA (Gedeon Richter) Recent Developments/Updates
7.7.6 BEMFOLA (Gedeon Richter) Competitive Strengths & Weaknesses
7.8 Follitrope (LG Chem)
7.8.1 Follitrope (LG Chem) Details
7.8.2 Follitrope (LG Chem) Major Business
7.8.3 Follitrope (LG Chem) Recombinant FSH Injections Product and Services
7.8.4 Follitrope (LG Chem) Recombinant FSH Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Follitrope (LG Chem) Recent Developments/Updates
7.8.6 Follitrope (LG Chem) Competitive Strengths & Weaknesses
7.9 GenSci
7.9.1 GenSci Details
7.9.2 GenSci Major Business
7.9.3 GenSci Recombinant FSH Injections Product and Services
7.9.4 GenSci Recombinant FSH Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 GenSci Recent Developments/Updates
7.9.6 GenSci Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Recombinant FSH Injections Industry Chain
8.2 Recombinant FSH Injections Upstream Analysis
8.2.1 Recombinant FSH Injections Core Raw Materials
8.2.2 Main Manufacturers of Recombinant FSH Injections Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Recombinant FSH Injections Production Mode
8.6 Recombinant FSH Injections Procurement Model
8.7 Recombinant FSH Injections Industry Sales Model and Sales Channels
8.7.1 Recombinant FSH Injections Sales Model
8.7.2 Recombinant FSH Injections Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Recombinant FSH Injections Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Recombinant FSH Injections Production Value by Region (2019-2024) & (USD Million)
Table 3. World Recombinant FSH Injections Production Value by Region (2025-2030) & (USD Million)
Table 4. World Recombinant FSH Injections Production Value Market Share by Region (2019-2024)
Table 5. World Recombinant FSH Injections Production Value Market Share by Region (2025-2030)
Table 6. World Recombinant FSH Injections Production by Region (2019-2024) & (K Units)
Table 7. World Recombinant FSH Injections Production by Region (2025-2030) & (K Units)
Table 8. World Recombinant FSH Injections Production Market Share by Region (2019-2024)
Table 9. World Recombinant FSH Injections Production Market Share by Region (2025-2030)
Table 10. World Recombinant FSH Injections Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Recombinant FSH Injections Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Recombinant FSH Injections Major Market Trends
Table 13. World Recombinant FSH Injections Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Recombinant FSH Injections Consumption by Region (2019-2024) & (K Units)
Table 15. World Recombinant FSH Injections Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Recombinant FSH Injections Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Recombinant FSH Injections Producers in 2023
Table 18. World Recombinant FSH Injections Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Recombinant FSH Injections Producers in 2023
Table 20. World Recombinant FSH Injections Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Recombinant FSH Injections Company Evaluation Quadrant
Table 22. World Recombinant FSH Injections Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Recombinant FSH Injections Production Site of Key Manufacturer
Table 24. Recombinant FSH Injections Market: Company Product Type Footprint
Table 25. Recombinant FSH Injections Market: Company Product Application Footprint
Table 26. Recombinant FSH Injections Competitive Factors
Table 27. Recombinant FSH Injections New Entrant and Capacity Expansion Plans
Table 28. Recombinant FSH Injections Mergers & Acquisitions Activity
Table 29. United States VS China Recombinant FSH Injections Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Recombinant FSH Injections Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Recombinant FSH Injections Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Recombinant FSH Injections Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Recombinant FSH Injections Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Recombinant FSH Injections Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Recombinant FSH Injections Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Recombinant FSH Injections Production Market Share (2019-2024)
Table 37. China Based Recombinant FSH Injections Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Recombinant FSH Injections Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Recombinant FSH Injections Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Recombinant FSH Injections Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Recombinant FSH Injections Production Market Share (2019-2024)
Table 42. Rest of World Based Recombinant FSH Injections Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Recombinant FSH Injections Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Recombinant FSH Injections Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Recombinant FSH Injections Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Recombinant FSH Injections Production Market Share (2019-2024)
Table 47. World Recombinant FSH Injections Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Recombinant FSH Injections Production by Type (2019-2024) & (K Units)
Table 49. World Recombinant FSH Injections Production by Type (2025-2030) & (K Units)
Table 50. World Recombinant FSH Injections Production Value by Type (2019-2024) & (USD Million)
Table 51. World Recombinant FSH Injections Production Value by Type (2025-2030) & (USD Million)
Table 52. World Recombinant FSH Injections Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Recombinant FSH Injections Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Recombinant FSH Injections Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Recombinant FSH Injections Production by Application (2019-2024) & (K Units)
Table 56. World Recombinant FSH Injections Production by Application (2025-2030) & (K Units)
Table 57. World Recombinant FSH Injections Production Value by Application (2019-2024) & (USD Million)
Table 58. World Recombinant FSH Injections Production Value by Application (2025-2030) & (USD Million)
Table 59. World Recombinant FSH Injections Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Recombinant FSH Injections Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Gonal-F (Merck) Basic Information, Manufacturing Base and Competitors
Table 62. Gonal-F (Merck) Major Business
Table 63. Gonal-F (Merck) Recombinant FSH Injections Product and Services
Table 64. Gonal-F (Merck) Recombinant FSH Injections Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Gonal-F (Merck) Recent Developments/Updates
Table 66. Gonal-F (Merck) Competitive Strengths & Weaknesses
Table 67. Follistim (Organon) Basic Information, Manufacturing Base and Competitors
Table 68. Follistim (Organon) Major Business
Table 69. Follistim (Organon) Recombinant FSH Injections Product and Services
Table 70. Follistim (Organon) Recombinant FSH Injections Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Follistim (Organon) Recent Developments/Updates
Table 72. Follistim (Organon) Competitive Strengths & Weaknesses
Table 73. Bravelle (Ferring) Basic Information, Manufacturing Base and Competitors
Table 74. Bravelle (Ferring) Major Business
Table 75. Bravelle (Ferring) Recombinant FSH Injections Product and Services
Table 76. Bravelle (Ferring) Recombinant FSH Injections Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Bravelle (Ferring) Recent Developments/Updates
Table 78. Bravelle (Ferring) Competitive Strengths & Weaknesses
Table 79. Menopur (Ferring) Basic Information, Manufacturing Base and Competitors
Table 80. Menopur (Ferring) Major Business
Table 81. Menopur (Ferring) Recombinant FSH Injections Product and Services
Table 82. Menopur (Ferring) Recombinant FSH Injections Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Menopur (Ferring) Recent Developments/Updates
Table 84. Menopur (Ferring) Competitive Strengths & Weaknesses
Table 85. Fostimon (IBSA) Basic Information, Manufacturing Base and Competitors
Table 86. Fostimon (IBSA) Major Business
Table 87. Fostimon (IBSA) Recombinant FSH Injections Product and Services
Table 88. Fostimon (IBSA) Recombinant FSH Injections Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Fostimon (IBSA) Recent Developments/Updates
Table 90. Fostimon (IBSA) Competitive Strengths & Weaknesses
Table 91. Puregon (Organon) Basic Information, Manufacturing Base and Competitors
Table 92. Puregon (Organon) Major Business
Table 93. Puregon (Organon) Recombinant FSH Injections Product and Services
Table 94. Puregon (Organon) Recombinant FSH Injections Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Puregon (Organon) Recent Developments/Updates
Table 96. Puregon (Organon) Competitive Strengths & Weaknesses
Table 97. BEMFOLA (Gedeon Richter) Basic Information, Manufacturing Base and Competitors
Table 98. BEMFOLA (Gedeon Richter) Major Business
Table 99. BEMFOLA (Gedeon Richter) Recombinant FSH Injections Product and Services
Table 100. BEMFOLA (Gedeon Richter) Recombinant FSH Injections Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. BEMFOLA (Gedeon Richter) Recent Developments/Updates
Table 102. BEMFOLA (Gedeon Richter) Competitive Strengths & Weaknesses
Table 103. Follitrope (LG Chem) Basic Information, Manufacturing Base and Competitors
Table 104. Follitrope (LG Chem) Major Business
Table 105. Follitrope (LG Chem) Recombinant FSH Injections Product and Services
Table 106. Follitrope (LG Chem) Recombinant FSH Injections Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Follitrope (LG Chem) Recent Developments/Updates
Table 108. GenSci Basic Information, Manufacturing Base and Competitors
Table 109. GenSci Major Business
Table 110. GenSci Recombinant FSH Injections Product and Services
Table 111. GenSci Recombinant FSH Injections Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 112. Global Key Players of Recombinant FSH Injections Upstream (Raw Materials)
Table 113. Recombinant FSH Injections Typical Customers
Table 114. Recombinant FSH Injections Typical Distributors
LIST OF FIGURE
Figure 1. Recombinant FSH Injections Picture
Figure 2. World Recombinant FSH Injections Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Recombinant FSH Injections Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Recombinant FSH Injections Production (2019-2030) & (K Units)
Figure 5. World Recombinant FSH Injections Average Price (2019-2030) & (US$/Unit)
Figure 6. World Recombinant FSH Injections Production Value Market Share by Region (2019-2030)
Figure 7. World Recombinant FSH Injections Production Market Share by Region (2019-2030)
Figure 8. North America Recombinant FSH Injections Production (2019-2030) & (K Units)
Figure 9. Europe Recombinant FSH Injections Production (2019-2030) & (K Units)
Figure 10. China Recombinant FSH Injections Production (2019-2030) & (K Units)
Figure 11. Japan Recombinant FSH Injections Production (2019-2030) & (K Units)
Figure 12. Recombinant FSH Injections Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Recombinant FSH Injections Consumption (2019-2030) & (K Units)
Figure 15. World Recombinant FSH Injections Consumption Market Share by Region (2019-2030)
Figure 16. United States Recombinant FSH Injections Consumption (2019-2030) & (K Units)
Figure 17. China Recombinant FSH Injections Consumption (2019-2030) & (K Units)
Figure 18. Europe Recombinant FSH Injections Consumption (2019-2030) & (K Units)
Figure 19. Japan Recombinant FSH Injections Consumption (2019-2030) & (K Units)
Figure 20. South Korea Recombinant FSH Injections Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Recombinant FSH Injections Consumption (2019-2030) & (K Units)
Figure 22. India Recombinant FSH Injections Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Recombinant FSH Injections by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant FSH Injections Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant FSH Injections Markets in 2023
Figure 26. United States VS China: Recombinant FSH Injections Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Recombinant FSH Injections Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Recombinant FSH Injections Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Recombinant FSH Injections Production Market Share 2023
Figure 30. China Based Manufacturers Recombinant FSH Injections Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Recombinant FSH Injections Production Market Share 2023
Figure 32. World Recombinant FSH Injections Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Recombinant FSH Injections Production Value Market Share by Type in 2023
Figure 34. Powder
Figure 35. Liquid
Figure 36. World Recombinant FSH Injections Production Market Share by Type (2019-2030)
Figure 37. World Recombinant FSH Injections Production Value Market Share by Type (2019-2030)
Figure 38. World Recombinant FSH Injections Average Price by Type (2019-2030) & (US$/Unit)
Figure 39. World Recombinant FSH Injections Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Recombinant FSH Injections Production Value Market Share by Application in 2023
Figure 41. IVF and Embryo Transfer
Figure 42. Infertility Treatment
Figure 43. World Recombinant FSH Injections Production Market Share by Application (2019-2030)
Figure 44. World Recombinant FSH Injections Production Value Market Share by Application (2019-2030)
Figure 45. World Recombinant FSH Injections Average Price by Application (2019-2030) & (US$/Unit)
Figure 46. Recombinant FSH Injections Industry Chain
Figure 47. Recombinant FSH Injections Procurement Model
Figure 48. Recombinant FSH Injections Sales Model
Figure 49. Recombinant FSH Injections Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Table 1. World Recombinant FSH Injections Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Recombinant FSH Injections Production Value by Region (2019-2024) & (USD Million)
Table 3. World Recombinant FSH Injections Production Value by Region (2025-2030) & (USD Million)
Table 4. World Recombinant FSH Injections Production Value Market Share by Region (2019-2024)
Table 5. World Recombinant FSH Injections Production Value Market Share by Region (2025-2030)
Table 6. World Recombinant FSH Injections Production by Region (2019-2024) & (K Units)
Table 7. World Recombinant FSH Injections Production by Region (2025-2030) & (K Units)
Table 8. World Recombinant FSH Injections Production Market Share by Region (2019-2024)
Table 9. World Recombinant FSH Injections Production Market Share by Region (2025-2030)
Table 10. World Recombinant FSH Injections Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Recombinant FSH Injections Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Recombinant FSH Injections Major Market Trends
Table 13. World Recombinant FSH Injections Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Recombinant FSH Injections Consumption by Region (2019-2024) & (K Units)
Table 15. World Recombinant FSH Injections Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Recombinant FSH Injections Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Recombinant FSH Injections Producers in 2023
Table 18. World Recombinant FSH Injections Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Recombinant FSH Injections Producers in 2023
Table 20. World Recombinant FSH Injections Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Recombinant FSH Injections Company Evaluation Quadrant
Table 22. World Recombinant FSH Injections Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Recombinant FSH Injections Production Site of Key Manufacturer
Table 24. Recombinant FSH Injections Market: Company Product Type Footprint
Table 25. Recombinant FSH Injections Market: Company Product Application Footprint
Table 26. Recombinant FSH Injections Competitive Factors
Table 27. Recombinant FSH Injections New Entrant and Capacity Expansion Plans
Table 28. Recombinant FSH Injections Mergers & Acquisitions Activity
Table 29. United States VS China Recombinant FSH Injections Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Recombinant FSH Injections Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Recombinant FSH Injections Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Recombinant FSH Injections Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Recombinant FSH Injections Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Recombinant FSH Injections Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Recombinant FSH Injections Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Recombinant FSH Injections Production Market Share (2019-2024)
Table 37. China Based Recombinant FSH Injections Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Recombinant FSH Injections Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Recombinant FSH Injections Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Recombinant FSH Injections Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Recombinant FSH Injections Production Market Share (2019-2024)
Table 42. Rest of World Based Recombinant FSH Injections Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Recombinant FSH Injections Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Recombinant FSH Injections Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Recombinant FSH Injections Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Recombinant FSH Injections Production Market Share (2019-2024)
Table 47. World Recombinant FSH Injections Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Recombinant FSH Injections Production by Type (2019-2024) & (K Units)
Table 49. World Recombinant FSH Injections Production by Type (2025-2030) & (K Units)
Table 50. World Recombinant FSH Injections Production Value by Type (2019-2024) & (USD Million)
Table 51. World Recombinant FSH Injections Production Value by Type (2025-2030) & (USD Million)
Table 52. World Recombinant FSH Injections Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Recombinant FSH Injections Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Recombinant FSH Injections Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Recombinant FSH Injections Production by Application (2019-2024) & (K Units)
Table 56. World Recombinant FSH Injections Production by Application (2025-2030) & (K Units)
Table 57. World Recombinant FSH Injections Production Value by Application (2019-2024) & (USD Million)
Table 58. World Recombinant FSH Injections Production Value by Application (2025-2030) & (USD Million)
Table 59. World Recombinant FSH Injections Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Recombinant FSH Injections Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Gonal-F (Merck) Basic Information, Manufacturing Base and Competitors
Table 62. Gonal-F (Merck) Major Business
Table 63. Gonal-F (Merck) Recombinant FSH Injections Product and Services
Table 64. Gonal-F (Merck) Recombinant FSH Injections Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Gonal-F (Merck) Recent Developments/Updates
Table 66. Gonal-F (Merck) Competitive Strengths & Weaknesses
Table 67. Follistim (Organon) Basic Information, Manufacturing Base and Competitors
Table 68. Follistim (Organon) Major Business
Table 69. Follistim (Organon) Recombinant FSH Injections Product and Services
Table 70. Follistim (Organon) Recombinant FSH Injections Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Follistim (Organon) Recent Developments/Updates
Table 72. Follistim (Organon) Competitive Strengths & Weaknesses
Table 73. Bravelle (Ferring) Basic Information, Manufacturing Base and Competitors
Table 74. Bravelle (Ferring) Major Business
Table 75. Bravelle (Ferring) Recombinant FSH Injections Product and Services
Table 76. Bravelle (Ferring) Recombinant FSH Injections Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Bravelle (Ferring) Recent Developments/Updates
Table 78. Bravelle (Ferring) Competitive Strengths & Weaknesses
Table 79. Menopur (Ferring) Basic Information, Manufacturing Base and Competitors
Table 80. Menopur (Ferring) Major Business
Table 81. Menopur (Ferring) Recombinant FSH Injections Product and Services
Table 82. Menopur (Ferring) Recombinant FSH Injections Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Menopur (Ferring) Recent Developments/Updates
Table 84. Menopur (Ferring) Competitive Strengths & Weaknesses
Table 85. Fostimon (IBSA) Basic Information, Manufacturing Base and Competitors
Table 86. Fostimon (IBSA) Major Business
Table 87. Fostimon (IBSA) Recombinant FSH Injections Product and Services
Table 88. Fostimon (IBSA) Recombinant FSH Injections Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Fostimon (IBSA) Recent Developments/Updates
Table 90. Fostimon (IBSA) Competitive Strengths & Weaknesses
Table 91. Puregon (Organon) Basic Information, Manufacturing Base and Competitors
Table 92. Puregon (Organon) Major Business
Table 93. Puregon (Organon) Recombinant FSH Injections Product and Services
Table 94. Puregon (Organon) Recombinant FSH Injections Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Puregon (Organon) Recent Developments/Updates
Table 96. Puregon (Organon) Competitive Strengths & Weaknesses
Table 97. BEMFOLA (Gedeon Richter) Basic Information, Manufacturing Base and Competitors
Table 98. BEMFOLA (Gedeon Richter) Major Business
Table 99. BEMFOLA (Gedeon Richter) Recombinant FSH Injections Product and Services
Table 100. BEMFOLA (Gedeon Richter) Recombinant FSH Injections Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. BEMFOLA (Gedeon Richter) Recent Developments/Updates
Table 102. BEMFOLA (Gedeon Richter) Competitive Strengths & Weaknesses
Table 103. Follitrope (LG Chem) Basic Information, Manufacturing Base and Competitors
Table 104. Follitrope (LG Chem) Major Business
Table 105. Follitrope (LG Chem) Recombinant FSH Injections Product and Services
Table 106. Follitrope (LG Chem) Recombinant FSH Injections Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Follitrope (LG Chem) Recent Developments/Updates
Table 108. GenSci Basic Information, Manufacturing Base and Competitors
Table 109. GenSci Major Business
Table 110. GenSci Recombinant FSH Injections Product and Services
Table 111. GenSci Recombinant FSH Injections Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 112. Global Key Players of Recombinant FSH Injections Upstream (Raw Materials)
Table 113. Recombinant FSH Injections Typical Customers
Table 114. Recombinant FSH Injections Typical Distributors
LIST OF FIGURE
Figure 1. Recombinant FSH Injections Picture
Figure 2. World Recombinant FSH Injections Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Recombinant FSH Injections Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Recombinant FSH Injections Production (2019-2030) & (K Units)
Figure 5. World Recombinant FSH Injections Average Price (2019-2030) & (US$/Unit)
Figure 6. World Recombinant FSH Injections Production Value Market Share by Region (2019-2030)
Figure 7. World Recombinant FSH Injections Production Market Share by Region (2019-2030)
Figure 8. North America Recombinant FSH Injections Production (2019-2030) & (K Units)
Figure 9. Europe Recombinant FSH Injections Production (2019-2030) & (K Units)
Figure 10. China Recombinant FSH Injections Production (2019-2030) & (K Units)
Figure 11. Japan Recombinant FSH Injections Production (2019-2030) & (K Units)
Figure 12. Recombinant FSH Injections Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Recombinant FSH Injections Consumption (2019-2030) & (K Units)
Figure 15. World Recombinant FSH Injections Consumption Market Share by Region (2019-2030)
Figure 16. United States Recombinant FSH Injections Consumption (2019-2030) & (K Units)
Figure 17. China Recombinant FSH Injections Consumption (2019-2030) & (K Units)
Figure 18. Europe Recombinant FSH Injections Consumption (2019-2030) & (K Units)
Figure 19. Japan Recombinant FSH Injections Consumption (2019-2030) & (K Units)
Figure 20. South Korea Recombinant FSH Injections Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Recombinant FSH Injections Consumption (2019-2030) & (K Units)
Figure 22. India Recombinant FSH Injections Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Recombinant FSH Injections by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant FSH Injections Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant FSH Injections Markets in 2023
Figure 26. United States VS China: Recombinant FSH Injections Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Recombinant FSH Injections Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Recombinant FSH Injections Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Recombinant FSH Injections Production Market Share 2023
Figure 30. China Based Manufacturers Recombinant FSH Injections Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Recombinant FSH Injections Production Market Share 2023
Figure 32. World Recombinant FSH Injections Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Recombinant FSH Injections Production Value Market Share by Type in 2023
Figure 34. Powder
Figure 35. Liquid
Figure 36. World Recombinant FSH Injections Production Market Share by Type (2019-2030)
Figure 37. World Recombinant FSH Injections Production Value Market Share by Type (2019-2030)
Figure 38. World Recombinant FSH Injections Average Price by Type (2019-2030) & (US$/Unit)
Figure 39. World Recombinant FSH Injections Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Recombinant FSH Injections Production Value Market Share by Application in 2023
Figure 41. IVF and Embryo Transfer
Figure 42. Infertility Treatment
Figure 43. World Recombinant FSH Injections Production Market Share by Application (2019-2030)
Figure 44. World Recombinant FSH Injections Production Value Market Share by Application (2019-2030)
Figure 45. World Recombinant FSH Injections Average Price by Application (2019-2030) & (US$/Unit)
Figure 46. Recombinant FSH Injections Industry Chain
Figure 47. Recombinant FSH Injections Procurement Model
Figure 48. Recombinant FSH Injections Sales Model
Figure 49. Recombinant FSH Injections Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
